Filing Details
- Accession Number:
- 0001415889-22-002174
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-02 19:08:19
- Reporting Period:
- 2022-02-28
- Accepted Time:
- 2022-03-02 19:08:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1583107 | Theravance Biopharma Inc. | TBPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1898490 | Rhonda Farnum | C/O Theravance Biopharma Us, Inc. 901 Gateway Blvd South San Francisco CA 94080 | Svp, Comm & Medical Affairs | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2022-02-28 | 2,356 | $10.16 | 333,271 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 5/17/21.
- This transaction was executed in multiple trades at prices from $10.02 to $10.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
